{"id":"W2005373764","doi":"10.1007/s00223-012-9668-4","title":"A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data","year":2012,"lang":"en","type":"article","venue":"Calcified Tissue International","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Osteoporosis Canada","funders":"UCB Pharma; Procter and Gamble; Sanofi; Servier; Amgen; Pfizer; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Tolerability; Osteoporosis; Regimen; Bone mineral; Bisphosphonate; Randomized controlled trial; Dosing; Bone density; Internal medicine; Surgery; Urology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002583558,0.0005593734,0.00225902,0.0003681409,0.0002711975,0.0005065606,0.0006028923,0.001192433,0.002337453],"category_scores_gemma":[0.001834063,0.0002657629,0.001049857,0.0003991033,0.0004117384,0.0006426469,0.0002891135,0.00148315,0.0003460162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003583731,"about_ca_system_score_gemma":0.0006070692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006267059,"about_ca_topic_score_gemma":0.00179355,"domain_scores_codex":[0.9991416,0.0004782118,0.00007367333,0.00008910768,0.0001357994,0.00008160347],"domain_scores_gemma":[0.9990726,0.0002644393,0.0002892456,0.0001144455,0.00006542099,0.0001938931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8112695,0.01850595,0.003616147,0.001027123,0.001538042,0.0001397616,0.00008636288,0.001084835,0.01775555,0.0001602496,0.001574191,0.1432422],"study_design_scores_gemma":[0.6426707,0.3342685,0.01683727,0.00005109295,0.0008198188,0.0002259736,0.00001922723,0.001019606,0.001567753,0.000127121,0.002361011,0.00003204513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832456,0.01098793,0.001257136,0.0004714555,0.0002338991,0.001634805,0.0009336249,0.0001091874,0.001126251],"genre_scores_gemma":[0.9847177,0.005193087,0.003229185,0.0009973161,0.0004420864,0.002130253,0.001666694,0.0000184379,0.00160529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002583558,"threshold_uncertainty_score":0.01366335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1056898434296992,"score_gpt":0.4060140360066105,"score_spread":0.3003241925769112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}